Percutaneous transcatheter aortic valve implantation: assessing results, judging outcomes, and planning trials: the interventionalist perspective.

[1]  Johnson Dm,et al.  FDA's requirements for in-vitro performance data for prosthetic heart valves. , 1994 .

[2]  J. Gardin,et al.  Burden of valvular heart diseases: a population-based study , 2006, The Lancet.

[3]  N. Saoudi,et al.  Percutaneous transluminal balloon valvuloplasty of adult aortic stenosis: report of 92 cases. , 1987, Journal of the American College of Cardiology.

[4]  Bradley G Hammill,et al.  Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[5]  A. Galloway,et al.  Aortic valve replacement for aortic stenosis in persons aged 80 years and over. , 1991, The American journal of cardiology.

[6]  Patrick Royston,et al.  Generic, Simple Risk Stratification Model for Heart Valve Surgery , 2005, Circulation.

[7]  S. Nashef,et al.  The logistic EuroSCORE , 2003 .

[8]  P. Wenaweser,et al.  Percutaneous aortic valve replacement for severe aortic regurgitation in degenerated bioprosthesis: The first valve in valve procedure using the corevalve revalving system , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[9]  R. D'Agostino.  Propensity Scores in Cardiovascular Research , 2007, Circulation.

[10]  R. Salamon,et al.  Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[11]  P. Höglund,et al.  Early mortality in coronary bypass surgery: the EuroSCORE versus The Society of Thoracic Surgeons risk algorithm. , 2004, The Annals of thoracic surgery.

[12]  A. Cribier,et al.  Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. , 2006, Journal of the American College of Cardiology.

[13]  N. Borenstein,et al.  A repositionable valved stent for endovascular treatment of deteriorated bioprostheses. , 2006, Journal of the American College of Cardiology.

[14]  A. Taylor,et al.  Risk Stratification, Systematic Classification, and Anticipatory Management Strategies for Stent Fracture After Percutaneous Pulmonary Valve Implantation , 2007, Circulation.

[15]  Thomas Felderhoff,et al.  Percutaneous Implantation of the CoreValve Self-Expanding Valve Prosthesis in High-Risk Patients With Aortic Valve Disease: The Siegburg First-in-Man Study , 2006, Circulation.

[16]  R. Bergström,et al.  Long-term follow-up of morbidity and mortality after aortic valve replacement with a mechanical valve prosthesis. , 2000, European heart journal.

[17]  A. DeMaria,et al.  Observer variability in the quantitation of Doppler color flow jet areas for mitral and aortic regurgitation. , 1988, Journal of the American College of Cardiology.

[18]  Philippe Pibarot,et al.  Impact of Prosthesis-Patient Mismatch on Cardiac Events and Midterm Mortality After Aortic Valve Replacement in Patients With Pure Aortic Stenosis , 2006, Circulation.

[19]  M. Südkamp,et al.  Risk stratification in heart surgery: comparison of six score systems. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[20]  Assaf Bash,et al.  Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. , 2004, Journal of the American College of Cardiology.

[21]  M. Mack,et al.  Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. , 2008, The Journal of thoracic and cardiovascular surgery.

[22]  J Kachaner,et al.  Transcatheter implantation of a bovine valve in pulmonary position: a lamb study. , 2000, Circulation.

[23]  I. Palacios,et al.  Clinical and hemodynamic follow-up after percutaneous aortic valvuloplasty in the elderly. , 1988, The American journal of cardiology.

[24]  S. Rahimtoola,et al.  Perspective on valvular heart disease: an update. , 1989, Journal of the American College of Cardiology.

[25]  C. Otto,et al.  Timing of aortic valve surgery , 2000, Heart.

[26]  Thomas Walther,et al.  Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. , 2007, Journal of the American College of Cardiology.

[27]  A. Shroyer,et al.  The Society of Thoracic Surgeons National Cardiac Surgery Database: current risk assessment. , 1997, The Annals of thoracic surgery.

[28]  David Paniagua,et al.  First human case of retrograde transcatheter implantation of an aortic valve prosthesis. , 2005, Texas Heart Institute journal.

[29]  E. DeLong,et al.  Prediction of operative mortality after valve replacement surgery. , 2001, Journal of the American College of Cardiology.

[30]  Thomas Felderhoff,et al.  First report on a human percutaneous transluminal implantation of a self‐expanding valve prosthesis for interventional treatment of aortic valve stenosis , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[31]  Volkmar Falk,et al.  Minimally invasive transapical beating heart aortic valve implantation--proof of concept. , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[32]  Younes Boudjemline,et al.  Steps Toward Percutaneous Aortic Valve Replacement , 2002, Circulation.

[33]  P. Bonhoeffer,et al.  Percutaneous implantation of a valve in the descending aorta in lambs. , 2002, European heart journal.

[34]  I. Palacios,et al.  Three‐Year Outcome After Balloon Aortic Valvuloplast: Insights Into Prognosis of Valvular Aortic Stenosis , 1994, Circulation.

[35]  B. Franklin,et al.  Changes in the quality of life: a major goal of cardiac rehabilitation. , 2001, Journal of cardiopulmonary rehabilitation.

[36]  Grunkemeier Gl,et al.  Sample size requirements for evaluating heart valves with constant risk events. , 1994 .

[37]  S. Lemeshow,et al.  European system for cardiac operative risk evaluation (EuroSCORE). , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[38]  G. Hellige,et al.  Transarterial aortic valve replacement with a self expanding stent in pigs , 2004, Heart.

[39]  Lukas Altwegg,et al.  Percutaneous Transarterial Aortic Valve Replacement in Selected High-Risk Patients With Aortic Stenosis , 2007, Circulation.

[40]  R B D'Agostino,et al.  Intra- and interobserver reproducibility of Doppler-assessed indexes of left ventricular diastolic function in a population-based study (the Framingham Heart Study). , 1992, The American journal of cardiology.

[41]  A. DeMaria.  Clinical trials and clinical judgment. , 2008, Journal of the American College of Cardiology.

[42]  R. Bergström,et al.  Observed and relative survival after aortic valve replacement. , 2000, Journal of the American College of Cardiology.

[43]  Bram D. Zuckerman,et al.  FDA perspective on clinical trial design for cardiovascular devices. , 2006, The Annals of thoracic surgery.

[44]  W. Sapirstein.  Designing trials for testing prosthetic cardiac valves: a Food and Drug Administration perspective. , 2001, American heart journal.

[45]  Anson Cheung,et al.  Transapical Transcatheter Aortic Valve Implantation in Humans: Initial Clinical Experience , 2006, Circulation.

[46]  J M Hasenkam,et al.  Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. , 1992, European heart journal.

[47]  Alain Cribier,et al.  Acute Improvement in Global and Regional Left Ventricular Systolic Function After Percutaneous Heart Valve Implantation in Patients With Symptomatic Aortic Stenosis , 2004, Circulation.

[48]  B. Griffith,et al.  Aortic valve bypass for the high-risk patient with aortic stenosis. , 2006, The Annals of thoracic surgery.

[49]  T. Vassiliades,et al.  The clinical development of percutaneous heart valve technology: a position statement of the Society of Thoracic Surgeons (STS), the American Association for Thoracic Surgery (AATS), and the Society for Cardiovascular Angiography and Interventions (SCAI). , 2005, The Annals of thoracic surgery.

[50]  P. Höglund,et al.  Comparison of 19 pre-operative risk stratification models in open-heart surgery. , 2006, European heart journal.

[51]  G. Grunkemeier,et al.  Bayesian analysis: a new statistical paradigm for new technology. , 2002, The Annals of thoracic surgery.

[52]  M. Enriquez-Sarano,et al.  Impact of Prosthesis-Patient Mismatch on Long-Term Survival in Patients With Small St Jude Medical Mechanical Prostheses in the Aortic Position , 2006, Circulation.

[53]  W. O’Neill,et al.  Retrograde percutaneous aortic valve implantation for critical aortic stenosis , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[54]  G. Grunkemeier,et al.  Prosthetic heart valves: Objective Performance Criteria versus randomized clinical trial. , 2006, The Annals of thoracic surgery.

[55]  A. Berman,et al.  Predictors of event-free survival after balloon aortic valvuloplasty. , 1991, The New England journal of medicine.

[56]  Gordon H Guyatt,et al.  Exploration of the value of health-related quality-of-life information from clinical research and into clinical practice. , 2007, Mayo Clinic proceedings.

[57]  P. Nihoyannopoulos,et al.  Natural history of early aortic paraprosthetic regurgitation: a five-year follow-up. , 1999, American heart journal.

[58]  Christopher E. Buller,et al.  Percutaneous Aortic Valve Implantation Retrograde From the Femoral Artery , 2006, Circulation.

[59]  S. Nashef,et al.  Risk factors for early mortality after valve surgery in Europe in the 1990s: lessons from the EuroSCORE pilot program. , 2001, The Journal of heart valve disease.

[60]  S. Nashef,et al.  Eurp-pean system for cardiac operative risk evaluation (Euro SCORE) , 1999 .

[61]  R. McKay,et al.  The Mansfield Scientific Aortic Valvuloplasty Registry: overview of acute hemodynamic results and procedural complications. , 1991, Journal of the American College of Cardiology.

[62]  T. Jahnke,et al.  Percutaneous Valve Replacement: Significance of Different Delivery Systems In Vitro and In Vivo , 2006, CardioVascular and Interventional Radiology.

[63]  J. Daubert,et al.  Surgery for Aortic Stenosis in Elderly Patients: A study of Surgical Risk and Predictive Factors , 1994, Circulation.

[64]  B. Bridgewater,et al.  Limitations of additive EuroSCORE for measuring risk stratified mortality in combined coronary and valve surgery. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[65]  P. Bonhoeffer,et al.  Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction , 2000, The Lancet.

[66]  Philippe Pibarot,et al.  Impact of Valve Prosthesis-Patient Mismatch on Short-Term Mortality After Aortic Valve Replacement , 2003, Circulation.

[67]  Assaf Bash,et al.  Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis: First Human Case Description , 2002, Circulation.